Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRTP7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,536
Award facts
- Contract value 100% obligated
- $26,535.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,535.93 to AmerisourceBergen Drug Corp for the supply of Stelara (ustekinumab) 45 mg/0.5 mL syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This contract employs firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
Stelara is a biologic immunosuppressant medication used primarily for treatment of autoimmune and inflammatory conditions, representing the specialized pharmaceutical products that AmerisourceBergen supplies to support military and federal healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical distributor for the Defense Health Agency and other government healthcare entities. This delivery order exemplifies AmerisourceBergen's ongoing capability to fulfill federal medical procurement requirements for specialty medications across the military health system supply chain.
Quick answers
Who was awarded contract SPE2DB25FRTP7?
SPE2DB25FRTP7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FRTP7 worth?
The government has obligated $26,536 on SPE2DB25FRTP7.
Is contract SPE2DB25FRTP7 an order under another contract?
Yes. SPE2DB25FRTP7 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRTP7 competed?
The extent of competition for SPE2DB25FRTP7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award